ESR1 and breast cancer: Several studies have explored genetic ESR1 alterations, such as gene mutations resulting in a constitutively active ERα, as a cause of endocrine resistance of HR+ BC cells; on the other hand, genetic alterations leading to a loss of ERα expression have been much less investigated [27].